Liabilities / Assets
40th percentile
Higher debt load relative to assets than 40% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
40th percentile
Higher debt load relative to assets than 40% of similar nonprofits.
Liabilities / Revenue
26th percentile
Higher debt load relative to revenue than 26% of similar nonprofits.
Net Margin
90th percentile
Higher net margin than 90% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
98th percentile
Faster asset growth than 98% of similar nonprofits.
Revenue Growth
96th percentile
Faster revenue growth than 96% of similar nonprofits.
Assets
Up$450,076
Up $335,253 (+292%) from 2017
Net Assets
Up$430,593
Up $323,899 (+304%) from 2017
Liabilities
Up$19,484
Up $11,356 (+140%) from 2017
Revenue
Up$1,013,032
Up $631,574 (+166%) from 2017
Expenses
Up$537,474
Up $140,893 (+36%) from 2017
Net Income
Up$475,558
Up $490,681 (+3245%) from 2017
This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To provide and facilitate access to objective, accurate, and non-judgmental information about psychoactive plants, chemicals, drugs, technologies, and related issues that affect the mind, body, and culture. Erowid Center supports and trains libraries, publishers, and other information distributors on issues related to our field. Further, it is Erowid Center's goal to support medical, legal, scientific, academic, and independent experts in developing and publishing related resources.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2018 • Form 990Summary only. Only limited summary data is available for this year.